Searched for
ANTHEM BIOSCIENCES FINANCIALS
Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...- Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in AprilQuant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...
- Quant Mid Cap Fund makes complete exit from IRCTC and increases stake in Anthem Biosciences and 4 otherQuant Mid Cap Fund exited IRCTC in December, sold GMR Airports shares, and added stakes in Anthem Biosciences, PB Fintech, SBI Cards, Premi...
- Anthem Biosciences shares surge 46% since listing amid strong financial growthAnthem Biosciences shares have risen significantly since its listing. The company reported strong June quarter results, boosting investor c...
- Quant Small Cap Fund hikes stake in Jio Financial Services in JulyQuant Small Cap Fund raised its stake in Jio Financial Services in July, adding nearly 45 lakh shares. The fund also increased exposure to ...
- Sensex rises! These stocks rallied over 15% on BSE in today's tradeIn the Nifty50 index, 31 stocks closed in the green, while 19 stocks ended in the red.
- Anthem Biosciences shares list at 27% premium over IPO priceAnthem Biosciences share price listed at a premium after its IPO. The IPO was subscribed 67.4 times. Qualified institutional buyers showed ...
- Anthem Biosciences shares rally 3% after healthy listing. Should you buy now?Anthem Biosciences share price: Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the ...
- Anthem Biosciences IPO: What GMP signals ahead of listing on MondayAnthem Biosciences will debut on stock exchanges on Monday, July 21, with grey market signals suggesting a potential 29% listing gain over ...
- Anthem Biosciences IPO subscribed 4x on last day; Check GMP, and other key detailsAnthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non...
- Anthem Biosciences IPO subscribed 2x on day 2; Check GMP, and other key detailsAnthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs. Brokerages recommend ...
- Anthem Biosciences' Rs 3,395 crore IPO opens for subscription. Should you bid?Anthem Biosciences launched its IPO on July 14, featuring an offer for sale of Rs 3,395 crore. The Bengaluru-based CRDMO, with a price band...
- Is Anthem Biosciences IPO a risky bet for investors?Anthem Biosciences, a CRDMO, is set to launch an IPO to raise ₹3,395 crore, diluting the promoter group's stake. While revenue and profit h...
- IPO Calendar: 3 new issues eye Rs 3,600 crore as primary market momentum continuesThree IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With str...
- Anthem Biosciences sets IPO price band at Rs 540-570/shareAnthem Biosciences is launching its IPO from July 14-16. The price is fixed between Rs 540 to Rs 570. The IPO aims to raise Rs 3,395 crore ...
- Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14Anthem Biosciences' Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CR...
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters and investors....
- Anthem Biosciences appoints JM Financial, Citi, JP Morgan as bankers for IPOAnthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3...
- Anthem Bio catches global buyout funds' eye, stake sale could see valuation rocket to $1 billionLaunched by ex-Biocon executive Ajay Bharadwaj, the Rs 1,200 crore Anthem Biosciences competes with Syngene International and GVK Bio. O3 C...
Load More
